# OnCo record xtop-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/xtop-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "xtop-biotherapeutics" ;
  schema:name "XTOP Biotherapeutics"@en ;
  schema:alternateName "XTOP BIOTHERAPEUTICS INC."@en ;
  schema:description "XTOP Biotherapeutics is a Worcester, Massachusetts company that designs antibodies binding three targets at once to steer T cells onto cancer cells. Its lead, CB-101, is aimed at colon, pancreatic and lung cancers."@en ;
  schema:url <https://onco.cc/companies/xtop-biotherapeutics/>, <https://www.xtopbiotherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.xtopbiotherapeutics.com/>, <https://www.xtopbiotherapeutics.com/pipeline/pipeline>, <https://reporter.nih.gov/project-details/11407471> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/trispecific-antibodies/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/ror1/>, <https://onco.cc/targets/epcam/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/cb-101/> .